204 related articles for article (PubMed ID: 12845558)
1. Testosterone undecanoate: a useful tool for testosterone administration in rats.
Callies F; Kollenkirchen U; von zur Mühlen C; Tomaszewski M; Beer S; Allolio B
Exp Clin Endocrinol Diabetes; 2003 Jun; 111(4):203-8. PubMed ID: 12845558
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneously administrated genistein and daidzein decrease serum cholesterol and increase triglyceride levels in male middle-aged rats.
Sosić-Jurjević B; Filipović B; Ajdzanović V; Brkić D; Ristić N; Stojanoski MM; Nestorović N; Trifunović S; Sekulić M
Exp Biol Med (Maywood); 2007 Oct; 232(9):1222-7. PubMed ID: 17895530
[TBL] [Abstract][Full Text] [Related]
3. Orchiectomy upregulates free soluble RANKL in bone marrow of aged rats.
Proell V; Xu H; Schüler C; Weber K; Hofbauer LC; Erben RG
Bone; 2009 Oct; 45(4):677-81. PubMed ID: 19501680
[TBL] [Abstract][Full Text] [Related]
4. Preventive role of exogenous testosterone on cisplatin-induced gonadal toxicity: an experimental placebo-controlled prospective trial.
Aminsharifi A; Shakeri S; Ariafar A; Moeinjahromi B; Kumar PV; Karbalaeedoost S
Fertil Steril; 2010 Mar; 93(5):1388-93. PubMed ID: 19362306
[TBL] [Abstract][Full Text] [Related]
5. Intramuscular testosterone enanthate plus very low dosage oral levonorgestrel suppresses spermatogenesis without causing weight gain in normal young men: a randomized clinical trial.
Anawalt BD; Amory JK; Herbst KL; Coviello AD; Page ST; Bremner WJ; Matsumoto AM
J Androl; 2005; 26(3):405-13. PubMed ID: 15867009
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of 5alpha-reductase blocks prostate effects of testosterone without blocking anabolic effects.
Borst SE; Lee JH; Conover CF
Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E222-7. PubMed ID: 15367394
[TBL] [Abstract][Full Text] [Related]
7. Blood flow and mineral content of the tibia of female and male rats: changes following castration and/or administration of estradiol or testosterone.
Kapitola J; Kubícková J; Andrle J
Bone; 1995 Jan; 16(1):69-72. PubMed ID: 7742086
[TBL] [Abstract][Full Text] [Related]
8. Androgen treatment prevents loss of cancellous bone in the orchidectomized rat.
Wakley GK; Schutte HD; Hannon KS; Turner RT
J Bone Miner Res; 1991 Apr; 6(4):325-30. PubMed ID: 1858518
[TBL] [Abstract][Full Text] [Related]
9. Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II study.
von Eckardstein S; Nieschlag E
J Androl; 2002; 23(3):419-25. PubMed ID: 12002444
[TBL] [Abstract][Full Text] [Related]
10. Trials for development of once-a-month injectable, hormonal male contraceptive using dienogest plus testosterone undecanoate: dose standardization, efficacy and reversibility studies in rats.
Misro MM; Chaki SP; Kaushik MC; Nandan D
Contraception; 2009 Jun; 79(6):488-97. PubMed ID: 19442786
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of injectable testosterone undecanoate in castrated cynomolgus monkeys (Macaca fascicularis) are independent of different oil vehicles.
Wistuba J; Marc Luetjens C; Kamischke A; Gu YQ; Schlatt S; Simoni M; Nieschlag E
J Med Primatol; 2005 Aug; 34(4):178-87. PubMed ID: 16053495
[TBL] [Abstract][Full Text] [Related]
12. Testosterone inhibition of growth hormone release stimulated by a growth hormone secretagogue: studies in the rat and dog.
Rigamonti AE; Cella SG; Giordani C; Bonomo SM; Giunta M; Sartorio A; Muller E
Neuroendocrinology; 2006; 84(2):115-22. PubMed ID: 17106185
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of a parenteral testosterone microsphere formulation in the male rat. Demonstration of dose dependence and controlled release.
Peacock NR; Swerdloff RS; Berman N; Gilley RM; Tice TR; Bhasin S
J Androl; 1993; 14(1):45-52. PubMed ID: 8473236
[TBL] [Abstract][Full Text] [Related]
14. Retrospective investigation of testosterone undecanoate depot for the long-term treatment of male hypogonadism in clinical practice.
Conaglen HM; Paul RG; Yarndley T; Kamp J; Elston MS; Conaglen JV
J Sex Med; 2014 Feb; 11(2):574-82. PubMed ID: 24279472
[TBL] [Abstract][Full Text] [Related]
15. Serum testosterone and bioavailable testosterone correlate with age and body size in hypogonadal men treated with testosterone undecanoate (1000 mg IM--Nebido).
Moisey R; Swinburne J; Orme S
Clin Endocrinol (Oxf); 2008 Oct; 69(4):642-7. PubMed ID: 18394021
[TBL] [Abstract][Full Text] [Related]
16. Anabolic and androgenic activity of 19-norandrostenedione after oral and subcutaneous administration--analysis of side effects and metabolism.
Parr MK; Laudenbach-Leschowsky U; Höfer N; Schänzer W; Diel P
Toxicol Lett; 2009 Jul; 188(2):137-41. PubMed ID: 19446246
[TBL] [Abstract][Full Text] [Related]
17. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
Irwin RD
Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
[TBL] [Abstract][Full Text] [Related]
18. Continuous testosterone administration prevents skeletal muscle atrophy and enhances resistance to fatigue in orchidectomized male mice.
Axell AM; MacLean HE; Plant DR; Harcourt LJ; Davis JA; Jimenez M; Handelsman DJ; Lynch GS; Zajac JD
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E506-16. PubMed ID: 16621900
[TBL] [Abstract][Full Text] [Related]
19. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
20. Testosterone release rate and duration of action of testosterone pellet implants.
Kelleher S; Howe C; Conway AJ; Handelsman DJ
Clin Endocrinol (Oxf); 2004 Apr; 60(4):420-8. PubMed ID: 15049955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
